Reclaim Focus: Overcome the Pitfalls of Shallow Learning 8 hours ...

But job satisfaction is just one piece of a more complex puzzle. Commitment to an organization goes beyond liking your job. In organizational psychology, we’ve long understood that commitment ...

DCA is a targeted therapy that inhibits Pyruvate Dehydrogenase ... production by mitochondria. "This NDA acceptance brings us one step closer to addressing the critical health challenges faced ...

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September 14, 2025. This NDA acceptance ... easy-to-use outpatient therapy for patients with fluid overload.

Recombinant FGF7 is Food and Drug Administration approved for the treatment of chemoradiation-induced oral mucositis. Research into the application of FGF7 to treat conditions such as graft-versus ...

12, 2024 — Excessive screen use ... activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a new ... Sleeping for 2: Insomnia Therapy ...

Drug therapy (or pharmacotherapy) involves the administration of drugs to treat or prevent disease. In some cases – often in the treatment of disease such as cancer, HIV infection and diabetes ...

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September 14, 2025. This NDA acceptance represents a pivotal milestone for Corstasis ... “This milestone brings us ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...